GBT Price Targets and Analyst Ratings NASDAQ:GBT
GBT Forecast. What You Should Know.
GBT Historical Ratings and Targets
About GLOBAL BLOOD THERAPEUTICS
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.